May 9, 2025 -- A new oral cancer drug combination has ... changes in blood test results (such as elevated liver enzyme and bilirubin levels, low hemoglobin levels and blood cell counts), eye ...

Luspatercept significantly improved red blood cell transfusion independence duration and overall survival in ESA-naive, lower ...

Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant ...

So is it time to add viruses to one's microbiome-feeding regimen of probiotics and prebiotics, synbiotics (which combine the ...

A low number ... such as the liver and kidneys — information that can be used later to determine the best treatment for your condition. Red blood cell tests may include a hemoglobin test or ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Protein is the **macro du jour**, influencers talk about this constantly. Trainers and dietitians create many recipes on ...

In pancreatic cancer, metastasis is often the first sign that a patient even has cancer, and by then, the cancer has spread ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

Studies have shown that inflammation and unhealthy ageing contribute to the development of non-viral liver cancer. However, researchers have now discovered that drinking one type of tea could ...